Alphabet Surges After Easily Beating Estimates, New $70 Billion Stock Buyback
In our preview of Alphabet’s Q1 earnings, we said the company was “Cheap, Room For Error, And Optimism Worst Is Over“, and sure enough, the company is surging after hours after the company reported earnings that largely beat expectations across the board, including capex (with the exception of cloud which came in light on revenue but more than made up for it on profit).
Here is what the company just reported for Q1:
- EPS $2.81 vs. $1.89 y/y, smashed estimate $2.01 (Bloomberg Consensus)
- Revenue ex-TAC $76.49 billion, +13% y/y, beat estimate $75.4 billion
- Total TAC $13.75 billion, +6.2% y/y, higher than estimated $13.66 billion
- Revenue $90.23 billion, +12% y/y, beat estimate $89.1 billion
- Google Services revenue $77.26 billion, +9.8% y/y, beat estimate $76.31 billion
- Google advertising revenue $66.89 billion, +8.5% y/y, beat estimate $66.39 billion
- Google Search & Other Revenue $50.70 billion, -6.2% q/q, beat estimate $50.3 billion
- YouTube ads revenue $8.93 billion, +10% y/y, missed estimate $8.94 billion
- Google Network Revenue $7.26 billion, -8.8% q/q, beat estimate $7.13 billion
- Google Subscriptions, Platforms and Devices Revenue $10.38 billion, -11% q/q, beat estimate $9.91 billion
- Google Cloud revenue $12.26 billion, +28% y/y, missed estimate $12.32 billion
- Other Bets revenue $450 million, -9.1% y/y, missed estimate $473.9 million
- Operating income $30.61 billion, +20% y/y, beat estimate $28.86 billion
- Google Services operating income $32.68 billion, +17% y/y, estimate $30.42 billion
- Google Cloud operating income $2.18 billion vs. $900 million y/y, estimate $1.94 billion
- Other Bets operating loss $1.23 billion, +20% y/y, estimate loss $1.12 billion
- Operating margin 34% vs. 32% y/y, beat estimate 32.3%
Number of employees 185,719, +2.7% y/y, estimate 183,718
Notably, in a time when many are expecting capex to be slashed, Alphabet’s capital expenditures came in hotter than expected, at $17.2BN, up 43% YoY, and just above the median estimate of $17.1BN.
Commenting on the quarter, Sundar Pichai, CEO, said: “We’re pleased with our strong Q1 results, which reflect healthy growth and momentum across the business. Underpinning this growth is our unique full stack approach to AI. This quarter was super exciting as we rolled out Gemini 2.5, our most intelligent AI model, which is achieving breakthroughs in performance and is an extraordinary foundation for our future innovation. Search saw continued strong growth, boosted by the engagement we’re seeing with features like AI Overviews, which now has 1.5 billion users per month. Driven by YouTube and Google One, we surpassed 270 million paid subscriptions. And Cloud grew rapidly with significant demand for our solutions.”
That said, Alphabet needs to ensure momentum in its search advertising and cloud businesses in order to justify its heightened investment in the artificial intelligence race. Competition is prompting the company and its rivals to spend heavily on infrastructure, research and talent, and as noted above, While Google benefits from AI startups spending on its cloud and business tools, it’s also racing to present an answer to popular conversational AI chatbots, which consumers are beginning to think of as an alternative to using Google Search.
Google’s beginning of the answer to that threat: its “AI Overviews” and “AI Mode” in search, in which summarized responses are drafted by generative AI and highlighted ahead of Google’s web links, have seen mixed success. Meanwhile, Google’s AI changes to search have decimated traffic to independent websites across the open web.
Tough for them, as for Alphabet, just to make sure the stock would not slump despite the solid beat, the company also announced a new $70 billion stock buyback authorization. Then again, with $75BN in LTM FCF and soaring capex, one wonders if GOOGL will soon need debt to meet all its funding needs.
GOOGL stock jumped as much as 5% after hours, precisely what the straddle implied move said it would do, rising just above $169 – the highest price since mid-March and well above its Liberation Day levels – before fading some of the gains.
Tyler Durden Thu, 04/24/2025 – 16:29
Source: https://freedombunker.com/2025/04/24/alphabet-surges-after-easily-beating-estimates-new-70-billion-stock-buyback/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
